Overview
- Mayo Clinic researchers demonstrated that AI-driven ECG and digital stethoscope tools can accurately detect left ventricular ejection fraction below 50% in women aged 18 to 49.
- The study, involving 200 women across two cohorts, revealed diagnostic accuracy with an AUC of 0.94 for the AI-ECG and 0.98 for the Eko DUO digital stethoscope.
- Positive screening rates in routine primary care were 1% for the AI-ECG and 3.2% for the AI-stethoscope, reflecting the tools' potential for broader clinical use.
- Licensing agreements with EKO Health and Anumana signal imminent clinical adoption, with revenue supporting Mayo Clinic's nonprofit mission.
- Further research is underway to assess the applicability of these AI tools in more diverse populations, aiming to modernize maternal healthcare and reduce cardiac-related mortality.